Hy2Care
Enschede
About Hy2Care
Hy2Care BV is a business start-up of the University of Twente, the Netherlands. It is Hy2Care’s ambition to introduce into the market the first cure for Osteoarthritis, the injectable hydrogel. Osteoarthritis is the 4th leading cause of mobility associated disability and affects more than 100 million patients in the Western world, who are all in need for an effective treatment. It is the aim of Hy2Care to change the future for patients suffering from osteoarthritis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $15.6M
- Last round: Series Unknown (May 2025)
- Website: hy2care.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/hy2care-132117 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.